Pathstone Holdings’s Opko Health OPK Stock Holding History

Pathstone Holdings’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,541	Closed	-$16.2K	–	2352
2024 Q4	$16.2K	Hold	10,541	–	–	﹤0.01%	2291
2024 Q3	$15.7K	Buy	+10,541	New	+$15.6K	﹤0.01%	2320

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Pathstone Holdings's OPK Position: Q1 2025 in Review

Pathstone Holdings sold out of Opko Health (OPK) in Q1 2025, closing a stake of 10,541 shares — an estimated $16.2K sold.

Pathstone Holdings first reported a position in OPK in Q3 2024 and held it in 2 quarters. The position peaked at $16.2K in Q4 2024. 255 funds tracked by Wall St. Rank hold OPK as of Q1 2025.

Pathstone Holdings reported no remaining Opko Health position as of Q1 2025 after selling out during the quarter.
Pathstone Holdings sold 10,541 Opko Health shares in Q1 2025, an estimated $16.2K.
Pathstone Holdings first reported a position in Opko Health in Q3 2024 and held it in 2 quarters.
Pathstone Holdings's Opko Health position peaked at $16.2K in Q4 2024.
255 funds tracked by Wall St. Rank held Opko Health as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.